Cargando…

Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.

Peripheral blood leucocytes from chronic myeloid leukaemia patients in remission were tested for inhibition of migration in presence of solubilized membrane antigens from leukaemic cells in 15 cases. Eight out of 9 autochthonous combinations (88-8%) and 35/49 allogenic combinations (71-4%) showed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gangal, S. G., Gothoskar, B. P., Joshi, C. S., Advani, S. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1976
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024985/ https://www.ncbi.nlm.nih.gov/pubmed/1063589

Ejemplares similares

Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
por: Gangal, S. G., et al.
Publicado: (1979)

In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.
por: Khare, A. G., et al.
Publicado: (1981)

Concanavalin A induced suppressor cell activity and autorosette forming cells in chronic myeloid leukemia patients.
por: Somasundaram, R., et al.
Publicado: (1983)

Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
por: Marti, J. H., et al.
Publicado: (1976)

Altered Ca(2+ )homeostasis in polymorphonuclear leukocytes from chronic myeloid leukaemia patients
por: Revankar, Chetana M, et al.
Publicado: (2006)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

Migration of Leucocytes in Passive Hyperæmia
por: Belfield, Wm. T.
Publicado: (1878)

Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.
por: Jones, B. M.
Publicado: (1976)

The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
por: Lopez, M., et al.
Publicado: (1978)

Chronic myeloid leukaemia with marked thrombocytosis
por: Ooi, Jun, et al.
Publicado: (2020)

THE IN VITRO ACTION OF HYDROCORTISONE ON LEUCOCYTE MIGRATION
por: Ketchel, Melvin M., et al.
Publicado: (1958)

Unilateral nasal obstruction: a rare presentation of acute myeloid leukaemia
por: Kelly, Mairead, et al.
Publicado: (2021)

Leucocyte-migration-inhibition test in patients with colorectal cancer: clinicopathological correlations.
por: Burtin, P., et al.
Publicado: (1978)

THE ACCELERATION AND INHIBITION OF MIGRATION OF HUMAN LEUCOCYTES IN VITRO BY PLASMA PROTEIN FRACTIONS
por: Ketchel, Melvin M., et al.
Publicado: (1955)

Chronic Myeloid Leukaemia in The 21st Century
por: Frazer, Rachel, et al.
Publicado: (2007)

COVID-19 in persons with chronic myeloid leukaemia
por: Li, Weiming, et al.
Publicado: (2020)

Isolated Ocular Manifestations in Chronic Myeloid Leukaemia
por: Maniam, Anita, et al.
Publicado: (2021)

Two ophthalmic presentations of chronic myeloid leukaemia
por: Kiernan, Miles, et al.
Publicado: (2022)

Receptors for human immunoglobulin on acute myeloid leukaemic leucocytes.
por: Ridway, J. C., et al.
Publicado: (1976)

Leucocytes from patients with colon carcinoma or non-cancerous intestinal disease react differently to foetal colon extract in leucocyte migration inhibition test.
por: Burtin, P., et al.
Publicado: (1980)

Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.
por: Vose, B. M., et al.
Publicado: (1979)

Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations.
por: Jones, B. M., et al.
Publicado: (1976)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Why are patients with chronic myeloid leukaemia (non-)adherent?
por: Abraham, I, et al.
Publicado: (2012)

The underestimated role of basophils in Ph(+) chronic myeloid leukaemia
por: Valent, Peter, et al.
Publicado: (2018)

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
por: Carrà, Giovanna, et al.
Publicado: (2019)

Acute abdomen in a patient with chronic myeloid leukaemia
por: Voppuru, Saiesh Reddy, et al.
Publicado: (2020)

Survival with chronic myeloid leukaemia after failing milestones
por: Lauseker, Michael, et al.
Publicado: (2023)

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.
por: Sargent, J. M., et al.
Publicado: (1989)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Organ-related and malignancy-associated reactivity of cancer patients' leucocytes: a leucocyte migration study with tumour and foetal extracts.
por: Matzku, S., et al.
Publicado: (1980)

Leucocyte migration inhibition under agarose versus MEM test for detection of tumour-associated antigens.
por: Emmrich, F., et al.
Publicado: (1978)

Epigenetic regulation of cathepsin L expression in chronic myeloid leukaemia
por: Samaiya, Misti, et al.
Publicado: (2011)

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment
por: Russo, D, et al.
Publicado: (2015)

Paediatric chronic myeloid leukaemia: Is it really a different disease?
por: Pushpam, Deepam, et al.
Publicado: (2019)

Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project
por: Botti, Stefano, et al.
Publicado: (2017)

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
por: Alikian, Mary, et al.
Publicado: (2017)

Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
por: Saglio, Giuseppe, et al.
Publicado: (2020)

Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
por: Poudel, Govinda, et al.
Publicado: (2022)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k40eav2o7b24df6og8o1l4qo7i